Methylation-dependent neurotransmitter synthesis

Methylation-dependent neurotransmitter synthesis refers to the set of biochemical mechanisms in which the addition of methyl groups (methylation) is required for the biosynthesis, regulation, or breakdown of neurotransmitters such as dopamine, serotonin, and acetylcholine, as well as for the epigenetic regulation of genes involved in neurotransmission. These processes primarily depend on the methionine cycle, which generates S-adenosylmethionine (SAM), the key methyl donor in the brain. Proper methylation is vital for neuronal function, synaptic plasticity, and cognitive processes. Impaired methylation can cause abnormal neurotransmitter levels and is implicate in the pathogenesis of neurodevelopmental, neurodegenerative, and psychiatric disorders. Since this is not a classical single molecular target, but a pathway/process, it is not considered a conventional therapeutic target like a specific enzyme, receptor, or transporter.

Other names

Methionine cycle in nervous systemSAM-dependent methylation in neurotransmitter synthesisS-adenosylmethionine-dependent neurotransmitter synthesis

Supplementation (e.g., SAMe, folate, vitamin B12) augments methyl donor availability, restoring methylation capacity and neurotransmitter balance. Inhibition (e.g., methotrexate) disrupts folate/methylation cycles and may affect neurotransmitter synthesis via secondary epigenetic effects.